These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30807227)

  • 21. Characteristics of pulmonary Mycobacterium avium complex disease diagnosed later in follow-up after negative mycobacterial study including bronchoscopy.
    Koyama K; Ohshima N; Kawashima M; Okuda K; Sato R; Nagai H; Matsui H; Ohta K
    Respir Med; 2015 Oct; 109(10):1347-53. PubMed ID: 26365483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.
    Shin SH; Jhun BW; Kim SY; Choe J; Jeon K; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104265
    [No Abstract]   [Full Text] [Related]  

  • 23. Characteristic chest CT findings for progressive cavities in Mycobacterium avium complex pulmonary disease: a retrospective cohort study.
    Oshitani Y; Kitada S; Edahiro R; Tsujino K; Kagawa H; Yoshimura K; Miki K; Miki M; Kida H
    Respir Res; 2020 Jan; 21(1):10. PubMed ID: 31915013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical outcomes in Mycobacterium xenopi versus Mycobacterium avium complex pulmonary disease: A retrospective matched cohort study.
    Zaheen A; Hirama T; Mehrabi M; Brode SK; Marras TK
    Respir Med; 2020 Jun; 167():105967. PubMed ID: 32421543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment Outcomes of Cavitary Nodular Bronchiectatic-Type Mycobacterium avium Complex Pulmonary Disease.
    Chae G; Park YE; Chong YP; Lee HJ; Shim TS; Jo KW
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0226121. PubMed ID: 35950842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment and outcome of non-tuberculous mycobacterial pulmonary disease in a predominantly fibro-cavitary disease cohort.
    Zweijpfenning S; Kops S; Magis-Escurra C; Boeree MJ; van Ingen J; Hoefsloot W
    Respir Med; 2017 Oct; 131():220-224. PubMed ID: 28947034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].
    Ogawa K; Sano C
    Kekkaku; 2013 Mar; 88(3):355-71. PubMed ID: 23672176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of patients with bronchoscopy-diagnosed pulmonary Mycobacterium avium complex infection.
    Urabe N; Sakamoto S; Sano G; Ito A; Homma S
    J Infect Chemother; 2018 Oct; 24(10):822-827. PubMed ID: 30054229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for deterioration of nodular bronchiectatic Mycobacterium avium complex lung disease.
    Kim SJ; Park J; Lee H; Lee YJ; Park JS; Cho YJ; Yoon HI; Lee CT; Lee JH
    Int J Tuberc Lung Dis; 2014 Jun; 18(6):730-6. PubMed ID: 24903946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical characteristics and treatment outcomes of pleural effusions in patients with nontuberculous mycobacterial disease.
    Park S; Jo KW; Lee SD; Kim WS; Shim TS
    Respir Med; 2017 Dec; 133():36-41. PubMed ID: 29173447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of emphysema on the prognosis of Mycobacterium avium complex pulmonary disease.
    Takasaka N; Hosaka Y; Fukuda T; Shinfuku K; Chida K; Shibata S; Kojima A; Hasegawa T; Yamada M; Yamanaka Y; Seki A; Seki Y; Ishikawa T; Kuwano K
    Respir Med; 2022 Feb; 192():106738. PubMed ID: 35051876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiplex cytokine analysis in Mycobacterium avium complex lung disease: relationship between CXCL10 and poor prognostic factors.
    Bamba Y; Moro H; Aoki N; Koizumi T; Ohshima Y; Watanabe S; Sakagami T; Koya T; Takada T; Kikuchi T
    BMC Infect Dis; 2019 Mar; 19(1):263. PubMed ID: 30885152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of clinical manifestations between Mycobacterium avium-intracellulare complex and Mycobacterium abscessus pulmonary diseases].
    Duan HF; Wang J; Chu NH; Huang XR; Wang QF; Huang HR; Liang Q
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Aug; 35(8):588-91. PubMed ID: 23158006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Redevelopment after spontaneous sputum conversion in noncavitary nodular bronchiectatic Mycobacterium avium complex lung disease.
    Kim OH; Chong YP; Shim TS; Jo KW
    J Infect Chemother; 2021 Aug; 27(8):1156-1161. PubMed ID: 33745810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of intermittent maintenance therapy after successful treatment of Mycobacterium avium complex lung disease.
    Asakura T; Nakagawa T; Suzuki S; Namkoong H; Morimoto K; Ishii M; Kurashima A; Betsuyaku T; Ogawa K; Hasegawa N;
    J Infect Chemother; 2019 Mar; 25(3):218-221. PubMed ID: 30172726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Non-tuberculous mycobacteriosis. What has been coming out].
    Kajiki A
    Kekkaku; 2011 Feb; 86(2):113-25. PubMed ID: 21404655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease.
    Hayashi M; Takayanagi N; Kanauchi T; Miyahara Y; Yanagisawa T; Sugita Y
    Am J Respir Crit Care Med; 2012 Mar; 185(5):575-83. PubMed ID: 22199005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The distribution and the characteristics in computed tomography (CT) of the lungs in primary Mycobacterium avium complex (MAC) infection].
    Kitahara Y; Harada Y; Harada S; Maruyama M; Kajiki A; Takamoto M; Ishibashi T
    Kekkaku; 1997 Apr; 72(4):173-80. PubMed ID: 9145646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal validity and prognostic significance of the St George's Respiratory Questionnaire in Mycobacterium avium complex pulmonary disease.
    Ogawa T; Asakura T; Suzuki S; Okamori S; Kusumoto T; Sato Y; Namkoong H; Kamata H; Ishii M; Fukunaga K; Hasegawa N
    Respir Med; 2021; 185():106515. PubMed ID: 34175804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of anti-glycopeptidolipid-core IgA antibodies in patients newly diagnosed with Mycobacterium avium complex lung disease.
    Matsuda S; Asakura T; Morimoto K; Suzuki S; Fujiwara K; Furuuchi K; Osawa T; Namkoong H; Ishii M; Kurashima A; Tatsumi K; Ohta K; Hasegawa N; Sasaki Y
    Respir Med; 2020 Sep; 171():106086. PubMed ID: 32917357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.